• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae.家族1和家族2的肺炎链球菌表面蛋白A(PspA)均能抑制补体沉积,并赋予肺炎链球菌3型荚膜血清型菌株毒力。
Infect Immun. 2003 Jan;71(1):75-85. doi: 10.1128/IAI.71.1.75-85.2003.
2
Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface.肺炎球菌表面蛋白A(PspA)及抗PspA抗体对补体激活和沉积的影响。
Infect Immun. 2004 Jan;72(1):114-22. doi: 10.1128/IAI.72.1.114-122.2004.
3
Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae.疫苗诱导产生的针对肺炎链球菌表面蛋白A(PspA)的人源抗体增强补体C3在肺炎链球菌上的沉积。
Microb Pathog. 2008 Mar;44(3):204-14. doi: 10.1016/j.micpath.2007.09.007. Epub 2007 Oct 11.
4
The virulence function of Streptococcus pneumoniae surface protein A involves inhibition of complement activation and impairment of complement receptor-mediated protection.肺炎链球菌表面蛋白A的毒力功能涉及抑制补体激活以及损害补体受体介导的保护作用。
J Immunol. 2004 Dec 15;173(12):7506-12. doi: 10.4049/jimmunol.173.12.7506.
5
Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae.肺炎球菌表面蛋白A抑制肺炎链球菌的补体激活。
Infect Immun. 1999 Sep;67(9):4720-4. doi: 10.1128/IAI.67.9.4720-4724.1999.
6
The absence of PspA or presence of antibody to PspA facilitates the complement-dependent phagocytosis of pneumococci in vitro.缺乏PspA或存在抗PspA抗体可促进体外肺炎球菌的补体依赖性吞噬作用。
Clin Vaccine Immunol. 2012 Oct;19(10):1574-82. doi: 10.1128/CVI.00393-12. Epub 2012 Aug 1.
7
Pneumolysin, PspA, and PspC contribute to pneumococcal evasion of early innate immune responses during bacteremia in mice.肺炎溶血素、肺炎球菌表面蛋白A(PspA)和肺炎球菌表面蛋白C(PspC)有助于肺炎球菌在小鼠菌血症期间逃避早期固有免疫反应。
Infect Immun. 2007 Apr;75(4):2067-70. doi: 10.1128/IAI.01727-06. Epub 2007 Jan 12.
8
Relative roles of genetic background and variation in PspA in the ability of antibodies to PspA to protect against capsular type 3 and 4 strains of Streptococcus pneumoniae.遗传背景和肺炎链球菌表面蛋白A(PspA)变异在抗PspA抗体抵御3型和4型肺炎链球菌菌株能力中的相对作用。
Infect Immun. 2003 Aug;71(8):4498-505. doi: 10.1128/IAI.71.8.4498-4505.2003.
9
Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine.肺炎球菌表面蛋白 A 通过与 C 反应蛋白竞争与细胞表面磷酰胆碱结合,从而抑制补体在肺炎球菌表面的沉积。
J Immunol. 2012 Dec 1;189(11):5327-35. doi: 10.4049/jimmunol.1201967. Epub 2012 Oct 26.
10
Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae.荚膜类型而非肺炎链球菌表面蛋白A(PspA)类型的基因改变会影响表面结合补体及肺炎链球菌表面抗原的可及性。
Infect Immun. 2003 Jan;71(1):218-25. doi: 10.1128/IAI.71.1.218-225.2003.

引用本文的文献

1
Safety and efficacy of an intramuscular bivalent vaccine against influenza and Streptococcus pneumoniae infections in mice.一种用于预防小鼠流感和肺炎链球菌感染的肌肉注射二价疫苗的安全性和有效性
Med Microbiol Immunol. 2025 Aug 29;214(1):39. doi: 10.1007/s00430-025-00848-w.
2
The ClpXP protease and the ClpX unfoldase control virulence, cell division, and autolysis in .ClpXP蛋白酶和ClpX解折叠酶控制着……中的毒力、细胞分裂和自溶作用。
Microbiol Spectr. 2025 Jul;13(7):e0080425. doi: 10.1128/spectrum.00804-25. Epub 2025 May 23.
3
Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections.表达肺炎球菌表面蛋白A的鼻内流感载体疫苗可预防流感和肺炎链球菌感染。
NPJ Vaccines. 2024 Dec 19;9(1):246. doi: 10.1038/s41541-024-01033-5.
4
Pneumococcal surface protein A (PspA) prevents killing of Streptococcus pneumoniae by indolicidin.肺炎球菌表面蛋白 A(PspA)可阻止杀菌肽 indolicidin 杀死肺炎链球菌。
Sci Rep. 2024 Oct 9;14(1):23517. doi: 10.1038/s41598-024-73564-9.
5
Naturally acquired antibodies against 4 Streptococcus pneumoniae serotypes in Pakistani adults with type 2 diabetes mellitus.巴基斯坦 2 型糖尿病成年患者中针对 4 种肺炎链球菌血清型的天然抗体。
PLoS One. 2024 Aug 9;19(8):e0306921. doi: 10.1371/journal.pone.0306921. eCollection 2024.
6
An immunoinformatics approach to epitope-based vaccine design against PspA in Streptococcus pneumoniae.一种基于免疫信息学方法的肺炎链球菌PspA表位疫苗设计
J Genet Eng Biotechnol. 2023 May 11;21(1):57. doi: 10.1186/s43141-023-00506-9.
7
Non-capsular based immunization approaches to prevent infection.基于非囊膜的免疫接种方法预防感染。
Front Cell Infect Microbiol. 2022 Sep 26;12:949469. doi: 10.3389/fcimb.2022.949469. eCollection 2022.
8
Pneumococcal Surface Proteins as Virulence Factors, Immunogens, and Conserved Vaccine Targets.肺炎球菌表面蛋白作为毒力因子、免疫原和保守疫苗靶标。
Front Cell Infect Microbiol. 2022 May 12;12:832254. doi: 10.3389/fcimb.2022.832254. eCollection 2022.
9
Pathogenicity and virulence of : Cutting to the chase on proteases.致病力和毒力:蛋白酶研究的关键
Virulence. 2021 Dec;12(1):766-787. doi: 10.1080/21505594.2021.1889812.
10
Sugar-Coated Killer: Serotype 3 Pneumococcal Disease.糖衣杀手:3型肺炎球菌疾病
Front Cell Infect Microbiol. 2020 Dec 23;10:613287. doi: 10.3389/fcimb.2020.613287. eCollection 2020.

本文引用的文献

1
Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates from Colombian children.来自哥伦比亚儿童侵袭性肺炎链球菌分离株的肺炎球菌表面蛋白A
Emerg Infect Dis. 2001 Sep-Oct;7(5):832-6. doi: 10.3201/eid0705.017510.
2
Complete genome sequence of a virulent isolate of Streptococcus pneumoniae.肺炎链球菌强毒株的全基因组序列
Science. 2001 Jul 20;293(5529):498-506. doi: 10.1126/science.1061217.
3
Characterization of selected strains of pneumococcal surface protein A.肺炎球菌表面蛋白A选定菌株的特性分析
J Biol Chem. 2001 Aug 31;276(35):33121-8. doi: 10.1074/jbc.M103304200. Epub 2001 Jun 18.
4
Characterization of binding of human lactoferrin to pneumococcal surface protein A.人乳铁蛋白与肺炎球菌表面蛋白A结合的特性分析。
Infect Immun. 2001 May;69(5):3372-81. doi: 10.1128/IAI.69.5.3372-3381.2001.
5
Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin.表现出对万古霉素耐受性的肺炎链球菌临床分离株。
Clin Infect Dis. 2001 Feb 15;32(4):552-8. doi: 10.1086/318697. Epub 2001 Feb 9.
6
Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae.肺炎溶血素是肺炎链球菌对脑微血管内皮细胞产生细胞毒性的主要诱导因子。
Infect Immun. 2001 Feb;69(2):845-52. doi: 10.1128/IAI.69.2.845-852.2001.
7
Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae.肺炎链球菌表面蛋白A(PspA)的多样性:嵌合基因及过去重组的证据
Infect Immun. 2000 Oct;68(10):5889-900. doi: 10.1128/IAI.68.10.5889-5900.2000.
8
Role of novel choline binding proteins in virulence of Streptococcus pneumoniae.新型胆碱结合蛋白在肺炎链球菌毒力中的作用
Infect Immun. 2000 Oct;68(10):5690-5. doi: 10.1128/IAI.68.10.5690-5695.2000.
9
Surface expression of lactoferrin by resting neutrophils.静息中性粒细胞乳铁蛋白的表面表达
Biochem Biophys Res Commun. 2000 Aug 18;275(1):241-6. doi: 10.1006/bbrc.2000.3284.
10
C3 as substrate for adhesion of Streptococcus pneumoniae.作为肺炎链球菌黏附底物的C3
J Infect Dis. 2000 Aug;182(2):497-508. doi: 10.1086/315722. Epub 2000 Jul 19.

家族1和家族2的肺炎链球菌表面蛋白A(PspA)均能抑制补体沉积,并赋予肺炎链球菌3型荚膜血清型菌株毒力。

Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae.

作者信息

Ren Bing, Szalai Alexander J, Thomas Orlanda, Hollingshead Susan K, Briles David E

机构信息

Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.

出版信息

Infect Immun. 2003 Jan;71(1):75-85. doi: 10.1128/IAI.71.1.75-85.2003.

DOI:10.1128/IAI.71.1.75-85.2003
PMID:12496151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC143380/
Abstract

Pneumococcal surface protein A (PspA), a virulence factor of Streptococcus pneumoniae, is exceptionally diverse, being classified into two major families which are over 50% divergent by sequence analysis. A family 1 PspA from strain WU2 was previously shown to impede the clearance of pneumococci from mouse blood and to interfere with complement deposition on the bacterial surface. To determine whether a family 2 PspA can perform the same role as family 1 PspA, the family 1 PspA (from strain WU2) was replaced with a family 2 PspA (from strain TIGR4) by molecular genetic methods to make an isogenic pair of strains expressing different PspA proteins. Surface binding of lactoferrin and interference with C3 deposition by the two types of PspA proteins were determined by flow cytometry, and virulence was assessed in a mouse bacteremia model. Although the family 2 PspA appeared to bind less human lactoferrin than did the family 1 PspA, both PspA proteins could interfere with complement deposition on the pneumococcal surface and could provide full virulence in the mouse infection model. A mutant form of the family 2 PspA with a deletion within the choline-binding region was also produced. Pneumococci with this mutant PspA failed to bind human lactoferrin even though the PspA was present on the pneumococcal surface. The mutant PspA only partially interfered with complement deposition and moderately attenuated virulence. These results suggest that family 1 and family 2 PspA proteins play similar roles in virulence and that surface accessibility of PspA is important for their function.

摘要

肺炎球菌表面蛋白A(PspA)是肺炎链球菌的一种毒力因子,具有极高的多样性,通过序列分析可分为两个主要家族,这两个家族的序列差异超过50%。先前研究表明,来自WU2菌株的1型PspA可阻碍肺炎球菌从小鼠血液中清除,并干扰补体在细菌表面的沉积。为了确定2型PspA是否能发挥与1型PspA相同的作用,通过分子遗传学方法将1型PspA(来自WU2菌株)替换为2型PspA(来自TIGR4菌株),从而构建出一对表达不同PspA蛋白的同基因菌株。通过流式细胞术测定两种类型的PspA蛋白与乳铁蛋白的表面结合情况以及对C3沉积的干扰作用,并在小鼠菌血症模型中评估其毒力。尽管2型PspA与1型PspA相比,似乎与人乳铁蛋白的结合较少,但两种PspA蛋白都能干扰补体在肺炎球菌表面的沉积,并且在小鼠感染模型中都具有完全的毒力。还产生了一种2型PspA的突变形式,其胆碱结合区域存在缺失。带有这种突变PspA的肺炎球菌即使PspA存在于肺炎球菌表面,也无法与人乳铁蛋白结合。突变型PspA仅部分干扰补体沉积,并适度减弱毒力。这些结果表明,1型和2型PspA蛋白在毒力方面发挥相似的作用,并且PspA的表面可及性对其功能很重要。